The Hair Growth Promoters / Anti-Hair Loss Agents Market is on a remarkable growth trajectory, with its valuation forecasted to surge from USD 2,108.5 million in 2025 to an impressive USD 4,909.4 ...
Trade Brains on MSN
Pharma stock jumps after announcing 3,000 Cr capex to set up greenfield formulations plant
The shares of this leading pharma company engaged in the business of manufacturing, developing and marketing a wide range of ...
The global Hair Thinning Solutions Market is on a strong growth trajectory, projected to surge from USD 6,201.2 million in ...
Mumbai-based drugmaker Sun Pharmaceutical Industries Ltd expects its India business to continue growing ahead of the market, supported by a strong focus on key therapies and brand building, Chief ...
Sun Pharmaceutical Industries has reported 2.6% rise in consolidated net profit to Rs 3,118 crore on a 8.6% increase in revenue to Rs 14,405.2 crore in Q2 FY26 as compared with Q2 FY25. Formulation ...
New Delhi: Pharma leader Sun Pharmaceutical Industries has recorded a Rs 3,118 crore net profit in Q2 FY26, up 2.56 percent, as India and emerging market sales drove growth. The company had reported a ...
Sun Pharmaceutical Industries officially announced here on Wednesday that it has reported a consolidated net profit of Rs 3,117.95 crore in the second quarter of FY26, registering a growth of 2.55% ...
Leading pharma company Sun Pharma is set to announce its second-quarter (Q2 FY26) results on November 5, 2025. Analysts expect a modest growth in revenue, driven by both domestic and international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback